Enterprise Value
50.53M
Cash
151.2M
Avg Qtr Burn
-12.88M
Short % of Float
8.03%
Insider Ownership
11.61%
Institutional Own.
64.13%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|